Last edition
News about "Quarterly Results "
JB Pharma Records Revenue Growth of 14 Percent to INR 896 Crores in Q1 FY24
For the first quarter of FY24 ended June 30, 2023, JB Pharma recorded revenue of INR 896 crores growing 14 percent from INR 785 crores in the corresponding quarter.
Quarterly Results | 09/08/2023 | By Manvi | 507
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members